Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ryoichi Ando

Showing results (31-40 of 37) with videos related to

Pageof 4
Sort By:
You have reached the last page of results.This site can display upto 37 results.
Scientific Reports|February 26, 2021
False-negative diagnosis of high anion gap in patients with end-stage kidney diseaseYou Komatsuzaki, Masato Ikeda, Akihiro Shimizu, et al.
Journal of Renal Nutrition : the Official Journal of the Council on Renal Nutrition of the National Kidney Foundation|August 12, 2018
Association of Circulatory Iron Deficiency With an Enlarged Heart in Patients With End-Stage Kidney DiseaseToshihide Hayashi, Yuri Tanaka, Masaki Iwasaki, et al.
Therapeutic Apheresis and Dialysis : Official Peer-Reviewed Journal of the International Society for Apheresis, the Japanese Society for Apheresis, the Japanese Society for Dialysis Therapy|May 21, 2011
Comparison between whole and intact parathyroid hormone assaysMasatomo Taniguchi, Motoko Tanaka, Takayuki Hamano, et al.
Bioorganic & Medicinal Chemistry Letters|October 8, 2013
6-(4-Pyridyl)pyrimidin-4(3H)-ones as CNS penetrant glycogen synthase kinase-3β inhibitorsFumiaki Uehara, Aya Shoda, Keiichi Aritomo, et al.
BMC Nephrology|July 20, 2013
Baseline characteristics and prevalence of cardiovascular disease in newly visiting or referred chronic kidney disease patients to nephrology centers in Japan: a prospective cohort studySoichiro Iimori, Yumi Noda, Tomokazu Okado, et al.
Therapeutic Apheresis and Dialysis : Official Peer-Reviewed Journal of the International Society for Apheresis, the Japanese Society for Apheresis, the Japanese Society for Dialysis Therapy|September 9, 2014
Multicenter study of pegylated interferon α-2a monotherapy for hepatitis C virus-infected patients on hemodialysis: REACH studyKan Kikuchi, Takashi Akiba, Kosaku Nitta, et al.
JAMA|December 12, 2018
Effect of Oral Alfacalcidol on Clinical Outcomes in Patients Without Secondary Hyperparathyroidism Receiving Maintenance Hemodialysis: The J-DAVID Randomized Clinical Trial, Tetsuo Shoji, Masaaki Inaba, et al.
Pageof 4

Showing results (31-40 of 37) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 37 results.
Scientific Reports|February 26, 2021
False-negative diagnosis of high anion gap in patients with end-stage kidney diseaseYou Komatsuzaki, Masato Ikeda, Akihiro Shimizu, et al.
Journal of Renal Nutrition : the Official Journal of the Council on Renal Nutrition of the National Kidney Foundation|August 12, 2018
Association of Circulatory Iron Deficiency With an Enlarged Heart in Patients With End-Stage Kidney DiseaseToshihide Hayashi, Yuri Tanaka, Masaki Iwasaki, et al.
Therapeutic Apheresis and Dialysis : Official Peer-Reviewed Journal of the International Society for Apheresis, the Japanese Society for Apheresis, the Japanese Society for Dialysis Therapy|May 21, 2011
Comparison between whole and intact parathyroid hormone assaysMasatomo Taniguchi, Motoko Tanaka, Takayuki Hamano, et al.
Bioorganic & Medicinal Chemistry Letters|October 8, 2013
6-(4-Pyridyl)pyrimidin-4(3H)-ones as CNS penetrant glycogen synthase kinase-3β inhibitorsFumiaki Uehara, Aya Shoda, Keiichi Aritomo, et al.
BMC Nephrology|July 20, 2013
Baseline characteristics and prevalence of cardiovascular disease in newly visiting or referred chronic kidney disease patients to nephrology centers in Japan: a prospective cohort studySoichiro Iimori, Yumi Noda, Tomokazu Okado, et al.
Therapeutic Apheresis and Dialysis : Official Peer-Reviewed Journal of the International Society for Apheresis, the Japanese Society for Apheresis, the Japanese Society for Dialysis Therapy|September 9, 2014
Multicenter study of pegylated interferon α-2a monotherapy for hepatitis C virus-infected patients on hemodialysis: REACH studyKan Kikuchi, Takashi Akiba, Kosaku Nitta, et al.
JAMA|December 12, 2018
Effect of Oral Alfacalcidol on Clinical Outcomes in Patients Without Secondary Hyperparathyroidism Receiving Maintenance Hemodialysis: The J-DAVID Randomized Clinical Trial, Tetsuo Shoji, Masaaki Inaba, et al.
Pageof 4